Morgan Stanley Codexis, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Codexis, Inc. stock. As of the latest transaction made, Morgan Stanley holds 479,853 shares of CDXS stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

479,853

Previous 444,234 8.02%

Holding current value

$1.31 Million

Previous $1.19 Million 2.01%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.97 - $2.64 $70,169 - $94,034	35,619 Added 8.02%	479,853 $1.17 Million
Q1 2025 May 15, 2025	SELL	$2.53 - $5.43 $671,811 - $1.44 Million	-265,538 Reduced 37.41%	444,234 $1.19 Million
Q4 2024 Feb 14, 2025	BUY	$2.91 - $5.81 $882,632 - $1.76 Million	303,310 Added 74.62%	709,772 $3.39 Million
Q3 2024 May 14, 2025	BUY	$2.62 - $3.71 $551,085 - $780,353	210,338 Added 107.25%	406,462 $1.25 Million
Q3 2024 Nov 14, 2024	BUY	$2.62 - $3.71 $551,085 - $780,353	210,338 Added 107.25%	406,462 $1.25 Million
Q2 2024 May 14, 2025	SELL	$2.65 - $3.92 $1.36 Million - $2.01 Million	-513,648 Reduced 72.37%	196,124 $607,000
Q2 2024 Oct 17, 2024	SELL	$2.65 - $3.92 $73,113 - $108,152	-27,590 Reduced 12.33%	196,124 $607,000
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $73,113 - $108,152	-27,590 Reduced 12.33%	196,124 $607,000
Q1 2024 Oct 17, 2024	BUY	$2.59 - $4.65 $71,458 - $128,293	27,590 Added 14.07%	223,714 $780,000
Q1 2024 Aug 16, 2024	SELL	$2.59 - $4.65 $366,479 - $657,965	-141,498 Reduced 38.74%	223,714 $780,000
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $366,479 - $657,965	-141,498 Reduced 38.74%	223,714 $780,000
Q4 2023 Aug 16, 2024	BUY	$1.54 - $3.37 $260,395 - $569,826	169,088 Added 86.21%	365,212 $1.11 Million
Q4 2023 Feb 13, 2024	BUY	$1.54 - $3.37 $56,250 - $123,092	36,526 Added 11.11%	365,212 $1.11 Million
Q3 2023 Nov 15, 2023	SELL	$1.5 - $3.75 $421,764 - $1.05 Million	-281,176 Reduced 46.1%	328,686 $621,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $237,440 - $475,954	-107,439 Reduced 14.98%	609,862 $1.71 Million
Q1 2023 May 15, 2023	SELL	$3.81 - $6.76 $521,474 - $925,241	-136,870 Reduced 16.02%	717,301 $2.97 Million
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $988,907 - $1.59 Million	232,138 Added 37.32%	854,171 $3.98 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $1.99 Million - $4.23 Million	328,583 Added 111.97%	622,033 $3.77 Million
Q2 2022 Oct 27, 2022	BUY	$8.35 - $21.89 $99,256 - $260,206	11,887 Added 4.22%	293,450 $3.07 Million
Q2 2022 Aug 15, 2022	BUY	$8.35 - $21.89 $99,256 - $260,206	11,887 Added 4.22%	293,450 $3.07 Million
Q1 2022 Oct 27, 2022	SELL	$16.97 - $31.93 $201,722 - $379,551	-11,887 Reduced 4.05%	281,563 $5.81 Million
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $2.54 Million - $4.78 Million	-149,712 Reduced 34.71%	281,563 $5.81 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $2.17 Million - $3.55 Million	84,851 Added 24.49%	431,275 $13.5 Million
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $6.81 Million - $9.7 Million	346,424 New	346,424 $8.06 Million

Others Institutions Holding CDXS

# of Institutions

129

Shares Held

69M

Call Options Held

25.8K

Put Options Held

20K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $179M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account